ROP
59
2
VLO
40
4
MKC
66
-2
EL
24
-4
MAC
37
6
AMGN
25
-5
XEL
62
2
MTB
59
3
CB
50
-5
NWL
35
3
DOV
59
2
KLAC
56
4
ECL
47
-7
NDAQ
56
3
RL
59
4
LUV
59
-2
NI
70
3
JBHT
38
2
URI
46
3
UHS
55
-3
ROP
59
2
VLO
40
4
MKC
66
-2
EL
24
-4
MAC
37
6
AMGN
25
-5
XEL
62
2
MTB
59
3
CB
50
-5
NWL
35
3
DOV
59
2
KLAC
56
4
ECL
47
-7
NDAQ
56
3
RL
59
4
LUV
59
-2
NI
70
3
JBHT
38
2
URI
46
3
UHS
55
-3
Financhill
Back

Citigroup Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
44

C
Citigroup

Last Price:
$67.24
Seasonality Move:
5.19%
Buy
55

SRPT
Sarepta Therapeutics

Last Price:
$98.39
Seasonality Move:
6.73%
Sell
44
Citigroup (C) is a Sell

Is Citigroup a Buy, Sell or Hold?

  • The current Citigroup [C] share price is $67.95. The Score for C is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • C is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Sarepta Therapeutics (SRPT) is a Buy

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $99.77. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

C Stock Price Chart

What is Citigroup's stock price today?

  • The Citigroup share price today is $67.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and C is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $99.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

C Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.6 Sell
Relative Strength Index (14 RSI): 27.42 Sell
Chaikin Money Flow: -573754 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (73.32 - 83.16) Sell
Bollinger Bands (100): (66.27 - 78.75) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.4 Sell
Relative Strength Index (14 RSI): 37.2 Sell
Chaikin Money Flow: -420668 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (103.16 - 112.22) Sell
Bollinger Bands (100): (109.63 - 127.19) Sell

C Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.37 Sell
20-day SMA: 77.72 Sell
50-day SMA: 77.14 Sell
200-day SMA: 67.18 Buy
8-day EMA: 71.73 Sell
20-day EMA: 75.47 Sell
50-day EMA: 75.92 Sell
200-day EMA: 68.31 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.49 Sell
20-day SMA: 106.07 Sell
50-day SMA: 113.88 Sell
200-day SMA: 126.52 Sell
8-day EMA: 103.1 Sell
20-day EMA: 106.21 Sell
50-day EMA: 111.8 Sell
200-day EMA: 120.79 Sell

Citigroup Earnings Growth & C Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.54 per share, an increase this year of $1.52 per share, and an increase next year of $1.79 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.52 per share, an increase next quarter of $0.05 per share, an increase this year of $6.65 per share, and an increase next year of $5.25 per share.

Citigroup Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):